Cainzos-Achirica, M. ., Varas-Lorenzo, C. ., Pottegard, A. ., Asmar, J. ., Plana, E. ., Rasmussen, L. ., … Pladevall-Vila, M. . (2018). Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4416
M. Cainzos-Achirica
First name
M.
Last name
Cainzos-Achirica
Fortuny, J. ., Gilsenan, A. ., Cainzos-Achirica, M. ., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L. ., … Andrews, E. B. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Saf. http://doi.org/10.1007/s40264-019-00836-z
Gilsenan, A. ., Fortuny, J. ., Cainzos-Achirica, M. ., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L. ., … Andrews, E. B. (2019). Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-019-00835-0
Ruigomez, A. ., Plana, E. ., Gilsenan, A. ., Fortuny, J. ., Cainzos-Achirica, M. ., Flynn, R. W. V., … Andrews, E. B. (2021). Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride. Drug Saf. http://doi.org/10.1007/s40264-021-01044-4